Thomas James Kaufman

Title: Thomas James Kaufman: Innovator in Bovine Vaccination

Introduction

Thomas James Kaufman is a notable inventor based in Lincoln, NE (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for bovine species. His work has the potential to improve animal health and agricultural productivity.

Latest Patents

Kaufman holds a patent for a Pasteurella haemolytica type A-1 bacterin-toxoid vaccine. This invention relates to the field of Pasteurella haemolytica vaccines. More specifically, it involves a bacterin-toxoid vaccine capable of inducing immunity in bovine species in one dose against Pasteurella haemolytica Type A-1 infection. The vaccine comprises Pasteurella haemolytica derived leukotoxoid, capsular antigen, soluble antigens, and cells. It also includes methods to make the vaccine and methods of vaccinating bovine animals. He has 1 patent to his name.

Career Highlights

Kaufman is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on innovative solutions that address critical health issues in livestock. His expertise in vaccine development is a valuable asset to the company.

Collaborations

Throughout his career, Kaufman has collaborated with esteemed colleagues, including Albert L. Brown and Krishnaswamy Iyengar Dayalu. These collaborations have contributed to advancements in veterinary vaccines and have fostered a spirit of innovation within the field.

Conclusion

Thomas James Kaufman is a distinguished inventor whose work in vaccine development has the potential to significantly impact animal health. His contributions to the field of veterinary medicine exemplify the importance of innovation in improving agricultural practices.